Collagen-based matrices with stem cells

US9867905B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9867905-B2
Application numberUS-33208408-A
CountryUS
Kind codeB2
Filing dateDec 10, 2008
Priority dateDec 10, 2007
Publication dateJan 16, 2018
Grant dateJan 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Collagen based-matrices and methods of their use are described. More particularly, collagen-based matrices for differentiating stem cells and progenitor cells, and for producing and isolating blood vessels and vascularized graft constructs are described.

First claim

Opening claim text (preview).

What is claimed is: 1. A tissue graft composition, said composition comprising: an engineered, purified collagen-based matrix comprising collagen fibrils, wherein the matrix has a collagen fibril microstructure including fibril-fibril branching; and a network of lumenized, endothelial cell-lined vessels formed in vitro, said vessels capable of persisting for more than 7 days in vitro; wherein said collagen fibrils are polymerized from a pig skin collagen source comprising a mixture of type I collagen monomers and oligomers, wherein the concentration of collagen in the polymerization reaction is 0.3 mg/ml to 1 mg/ml, wherein the vessels are formed from endothelial progenitor cells, and wherein the matrix has a shear storage modulus of 40 Pa to 50 Pa and a fibril volume fraction of 5% to 10%; and wherein the tissue graft composition is produced by engineering the purified collagen-based matrix, and seeding the matrix at a density of 1×10 5 to 5×10 5 endothelial progenitor cells per milliliter to form one or more vessels within the matrix. 2. The tissue graft composition of claim 1 , wherein said matrix has a loss modulus of from about 1 Pa to about 75 Pa. 3. The tissue graft composition of claim 1 , wherein said matrix has a compression modulus of 2,500 Pa to about 18,000 Pa.

Assignees

Inventors

Classifications

  • A61L27/507Primary

    for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title

  • A61L27/24Primary

    Collagen · CPC title

  • Endothelial cells · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

  • Stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9867905B2 cover?
Collagen based-matrices and methods of their use are described. More particularly, collagen-based matrices for differentiating stem cells and progenitor cells, and for producing and isolating blood vessels and vascularized graft constructs are described.
Who is the assignee on this patent?
Voytik-Harbin Sherry L, Kreger Seth, Yoder Mervin C, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61L27/507. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).